Unlike that of other Th subsets, pathological Th17 differentiation is inhibited by CD28 co-stimulation [31,34], suggesting that CD28 co-stimulatory signal inhibition by ABA treatment does not suppress the inflammatory cytokine-induced Th17 differentiation in patients with RA. This evidence concerns the gene CD28 and rheumatoid arthritis.